Should SGLT2 inhibitors be part of standard of care for patients with insufficiently controlled type 2 diabetes? (90 minutes Webinar)

Zeh, P. (Chair)

Activity: Participating in or organising an eventParticipation in workshop, seminar, course

Period17 Nov 2020
Event typeSeminar
LocationBirmingham, United Kingdom
Degree of RecognitionLocal